miR-96-5p regulated TGF-β/SMAD signaling pathway and suppressed endometrial cell viability and migration via targeting TGFBR1
Lab / animal
OA: bronze
CC0
RETRACTED
⤵ 13 in-corpus citations
Retraction notice. Marked retracted by OpenAlex; see publisher for the formal retraction notice.
AI-generated summary
This study found that miR-96-5p, downregulated in endometriosis, suppresses endometrial cell viability and migration by targeting TGFBR1 and inhibiting the TGF-β/SMAD signaling pathway.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
We previously performed high throughput RNA-seq in paired eutopic and ectopic endometrial specimen of endometriosis patients, and validated the results by qRT-PCR in endometriosis endometrial tissues. MiR-96-5p was significantly downregulated in ectopic endometrial tissues compared to eutopic tissues. In order to identify the role of miR-96-5p in endometriosis and endometrial cells, and investigate the underlying mechanisms, the Ishikawa and End1/E6E7 cell lines were transfected with miR-96-5p mimics, miR-96-5p inhibitors or TGFBR1 siRNA. The expression of TGF-β/SMAD signaling pathway components and epithelial-mesenchymal transition (EMT) markers were examined by qRT-PCR and western blot, and cell viability and migration were determined by CCK-8, transwell and wound healing assays, respectively. We discovered miR-96-5p to be significantly downregulated while TGFBR1 was distinctly up-regulated in endometriosis. Overexpression of miR-96-5p inhibited endometrial cells viability and migration, while inhibition of miR-96-5p had opposite effect. Furthermore, we confirmed TGFBR1 was a direct target of miR-96-5p. Overexpression of miR-96-5p could block the TGF-β/SMAD signaling pathway via targeting TGFBR1 and reverse the TGF-β1 induced EMT in endometrial cell lines. In conclusion, we demonstrated that miR-96-5p interacted with TGF-β/SMAD signaling pathway and blocked the TGF-β1 induced EMT in endometrial cells via directly targeting TGFBR1.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (32)
- Analysis of Serum microRNA Profile by Solexa Sequencing in Women With Endometriosis via openalex
- Association between ovarian cancer and advanced endometriosis via openalex
- Clinical practice. Endometriosis via openalex
- Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK via openalex
- Endometriosis and infertility: Insights into the causal link and management strategies via openalex
- Endometriosis Located Proximal to or Remote From the Uterus Differentially Affects Uterine Gene Expression via openalex
- Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology via openalex
- Erratum: MicroRNAs in endometriosis biological function and emerging biomarker candidates via openalex
- Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer via openalex
- The involvement of multifunctional TGF-β and related cytokines in pathogenesis of endometriosis via openalex
- The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review via openalex
- The peritoneum is both a source and target of TGF-β in women with endometriosis via openalex
- Transforming Growth Factor-beta 1 Involved in the Pathogenesis of Endometriosis through Regulating Expression of Vascular Endothelial Growth Factor under Hypoxia via openalex
- W1663371441 via openalex
- W2796959287 via openalex
- W2796971903 via openalex
- W2810127666 via openalex
- W2883981220 via openalex
- W2947694770 via openalex
- W2991459806 via openalex
- W3006606436 via openalex
- W1944770503 via openalex
- W4211081176 via openalex
- W1964081206 via openalex
- W1977119725 via openalex
- W2051190668 via openalex
- W2122211092 via openalex
- W2130229338 via openalex
- W2137373909 via openalex
- W2179263003 via openalex
- W2418947410 via openalex
- W1905151502 via openalex
Cited by (13)
- Identification and Validation of Potential Immune-Related Genes for Endometriosis 2025
- Exosomal miR-146a-5p mediates macrophage polarization through TRAF6/NF-κB signaling in endometriosis 2024
- Proteins in urine - Possible biomarkers of endometriosis 2023
- Identification of central genes for endometriosis through integration of single-cell RNA sequencing and bulk RNA sequencing analysis 2023
- Huayu Sanjie Enema Liquid Relieves Pain in Endometriosis Model Rats by Inhibiting Inflammation, Peripheral Sensitization, and Pelvic Adhesion 2022
- Integrated bioinformatic analysis of dysregulated microRNA-mRNA co-expression network in ovarian endometriosis 2022
- Identification of potential differentially methylated gene-related biomarkers in endometriosis 2022
- A review of the effects of estrogen and epithelial-mesenchymal transformation on intrauterine adhesion and endometriosis 2022
- MiR-143-3p facilitates motility and invasiveness of endometriotic stromal cells by targeting VASH1/TGF-β signaling 2022
- The activation of TGF-β signaling promotes cell migration and invasion of ectopic endometrium by targeting NRP2 2022
- The Search for Biomarkers in Endometriosis: a Long and Windy Road 2021
- Transcriptome-Based Analysis Reveals Therapeutic Effects of Resveratrol on Endometriosis in aRat Model 2021
- LINC01116 promotes proliferation and migration of endometrial stromal cells by targeting FOXP1 via sponging miR-9-5p in endometriosis 2020
Source provenance
- europepmc
- last seen: 2026-10-14T06:08:39.101224+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:27:56.761287+00:00
License: CC0
· commercial use OK